These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 32446108

  • 1. Cortisol awakening response in PTSD treatment: Predictor or mechanism of change.
    Rauch SAM, King A, Kim HM, Powell C, Rajaram N, Venners M, Simon NM, Hamner M, Liberzon I.
    Psychoneuroendocrinology; 2020 Aug; 118():104714. PubMed ID: 32446108
    [Abstract] [Full Text] [Related]

  • 2. The impact of PTSD treatment on the cortisol awakening response.
    Pacella ML, Feeny N, Zoellner L, Delahanty DL.
    Depress Anxiety; 2014 Oct; 31(10):862-9. PubMed ID: 25327949
    [Abstract] [Full Text] [Related]

  • 3. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial.
    Rauch SA, King AP, Abelson J, Tuerk PW, Smith E, Rothbaum BO, Clifton E, Defever A, Liberzon I.
    Depress Anxiety; 2015 Mar; 32(3):204-12. PubMed ID: 25639570
    [Abstract] [Full Text] [Related]

  • 4. Pre-treatment cortisol awakening response predicts symptom reduction in posttraumatic stress disorder after treatment.
    Rapcencu AE, Gorter R, Kennis M, van Rooij SJH, Geuze E.
    Psychoneuroendocrinology; 2017 Aug; 82():1-8. PubMed ID: 28482208
    [Abstract] [Full Text] [Related]

  • 5. Changes in Salivary Cortisol During Psychotherapy for Posttraumatic Stress Disorder: A Pilot Study in 30 Veterans.
    Rauch SAM, King AP, Liberzon I, Sripada RK.
    J Clin Psychiatry; 2017 May; 78(5):599-603. PubMed ID: 28102979
    [Abstract] [Full Text] [Related]

  • 6. Attachment impacts cortisol awakening response in chronically depressed individuals.
    Adams GC, Wrath AJ, von Dewitz B, Marciniuk K, Roesler A, Napper S.
    Psychoneuroendocrinology; 2020 Oct; 120():104778. PubMed ID: 32585509
    [Abstract] [Full Text] [Related]

  • 7. Altered cortisol awakening response in posttraumatic stress disorder.
    Wessa M, Rohleder N, Kirschbaum C, Flor H.
    Psychoneuroendocrinology; 2006 Feb; 31(2):209-15. PubMed ID: 16154709
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment cortisol predicts trauma-focused psychotherapy response in youth with (partial) posttraumatic stress disorder.
    Zantvoord JB, Ensink JBM, Op den Kelder R, Wessel AMA, Lok A, Lindauer RJL.
    Psychoneuroendocrinology; 2019 Nov; 109():104380. PubMed ID: 31352130
    [Abstract] [Full Text] [Related]

  • 9. Integrating biological treatment mechanisms into randomized clinical trials: Design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial).
    Rauch SAM, Simon NM, Kim HM, Acierno R, King AP, Norman SB, Venners MR, Porter K, Phan KL, Tuerk PW, Allard C, Liberzon I, Rothbaum BO, Martis B, Stein MB, Hoge CW.
    Contemp Clin Trials; 2018 Jan; 64():128-138. PubMed ID: 29081351
    [Abstract] [Full Text] [Related]

  • 10. Evidence for altered hypothalamus-pituitary-adrenal axis functioning in systemic hypertension: blunted cortisol response to awakening and lower negative feedback sensitivity.
    Wirtz PH, von Känel R, Emini L, Ruedisueli K, Groessbauer S, Maercker A, Ehlert U.
    Psychoneuroendocrinology; 2007 Jun; 32(5):430-6. PubMed ID: 17433557
    [Abstract] [Full Text] [Related]

  • 11. Cortisol awakening response in adolescents with acute sexual abuse related posttraumatic stress disorder.
    Keeshin BR, Strawn JR, Out D, Granger DA, Putnam FW.
    Depress Anxiety; 2014 Feb; 31(2):107-14. PubMed ID: 23893710
    [Abstract] [Full Text] [Related]

  • 12. Implications of hypothalamic-pituitary-adrenal axis functioning in posttraumatic stress disorder.
    Jones T, Moller MD.
    J Am Psychiatr Nurses Assoc; 2011 Feb; 17(6):393-403. PubMed ID: 22142976
    [Abstract] [Full Text] [Related]

  • 13. Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation.
    Barone JC, Ho A, Osborne LM, Eisenlohr-Moul TA, Morrow AL, Payne JL, Epperson CN, Hantsoo L.
    Psychoneuroendocrinology; 2024 Nov; 169():107145. PubMed ID: 39096755
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.
    Rauch SAM, Kim HM, Lederman S, Sullivan G, Acierno R, Tuerk PW, Simon NM, Venners MR, Norman SB, Allard CB, Porter KE, Martis B, Bui E, Baker AW, PROGrESS Team.
    J Clin Psychiatry; 2021 Jun 15; 82(4):. PubMed ID: 34133087
    [Abstract] [Full Text] [Related]

  • 16. Lower stress-reactive cortisol in female veterans associated with military status but not PTSD.
    Pierce ME, Pritchard LM.
    Stress; 2016 Sep 15; 19(5):486-91. PubMed ID: 27460501
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Basal blood DHEA-S/cortisol levels predicts EMDR treatment response in adolescents with PTSD.
    Usta MB, Gumus YY, Say GN, Bozkurt A, Şahin B, Karabekiroğlu K.
    Nord J Psychiatry; 2018 Apr 15; 72(3):164-172. PubMed ID: 29171317
    [Abstract] [Full Text] [Related]

  • 20. Variability of the cortisol awakening response and morning salivary oxytocin in late adolescence.
    Van Dam JM, Garrett AJ, Schneider LA, Buisman-Pijlman FTA, Short MA, Hodyl NA, Edwards HK, Goldsworthy MR, Pitcher JB.
    J Neuroendocrinol; 2018 Nov 15; 30(11):e12645. PubMed ID: 30216577
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.